Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023 | Evolving Opportunities with IQVIA and Lonza | Technavio

LONDON--()--Technavio has been monitoring the global pharmaceutical contract research and manufacturing (CRAM) market since 2016 and the market is poised to grow by USD 62.67 billion during 2019-2023, progressing at a CAGR of more than 9% during the forecast period. Request Free Sample Pages

Read the 114-page research report with TOC on "Pharmaceutical Contract Research and Manufacturing (CRAM) Market Analysis Report by Service (CRO and CMO), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 - 2023".

The market is driven by the availability of cost-efficient resources in emerging countries. In addition, the advent of big data is anticipated to further boost the growth of the pharmaceutical contract research and manufacturing (CRAM) market.

Advancements in technological and healthcare infrastructure are being witnessed in drug development processes in various emerging economies. This is encouraging the outsourcing of research and manufacturing operations of various drugs across developing nations. In addition, there is a high concentration of several US FDA-approved manufacturing plants in developing nations. These locations are most preferred for contract manufacturing due to the availability of cost-efficient resources in these countries. Thus, the presence of cost-efficient resources in emerging countries is expected to drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for FREE.

View market snapshot before purchasing

Major Five Pharmaceutical Contract Research and Manufacturing (CRAM) Market Companies:

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH is headquartered in Germany and owns and operates businesses under various segments such as human pharmaceuticals, animal health, and biopharmaceuticals. The company offers CMO.

Catalent, Inc

Catalent, Inc is headquartered in the US and it offers products through global business units: Softgel technologies, clinical supply services, BSDD, and oral drug delivery. The company offers CDAM.

IQVIA

IQVIA is headquartered in the US and has business operations under various segments, namely technology & analytics solutions, R&D solutions, and contract sales and medical solutions. The company offers CRO.

Lonza

Lonza is headquartered in Switzerland and offers products through pharma & biotech and specialty ingredients. The company offers CDAM, which includes the development, manufacturing, and commercialization of biological and small molecule-based drugs.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is headquartered in the US and offers products through business segments such as life sciences solutions, analytical instruments, and specialty diagnostics. The company offers CDAM, which includes preclinical and clinical trial research.

Register for a free trial today and gain instant access to 10,000+ market research reports. Technavio's SUBSCRIPTION platform

Pharmaceutical Contract Research and Manufacturing (CRAM) Services Outlook (Revenue, USD Million, 2019 - 2023)

  • Contract research organizations (CRO)
  • Contract manufacturing organizations (CMO)

Pharmaceutical Contract Research and Manufacturing (CRAM) Regional Outlook (Revenue, USD Million, 2019 - 2023)

  • Asia
  • Europe
  • North America
  • ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Health Care are:

Pharmacovigilance and Drug Safety Software Market – Global Pharmacovigilance and Drug Safety Software Market by end-users (pharmaceutical and biotechnology companies, contract research organization, and business process outsourcing) and geography (Asia, Europe, North America, and ROW).

Pyrogen Testing Market – Global Pyrogen Testing Market by end-user (pharmaceutical and biotechnology companies, medical devices companies, and food and beverage manufacturers) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: https://www.technavio.com

Release Summary

Global pharmaceutical contract research and manufacturing (CRAM) market is poised to grow by USD 62.67 billion during 2019-2023.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: https://www.technavio.com